Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan, a Three-year Prospective Study

NCT05750043 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT05750043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05750043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan, a Three-year Prospective Study
Lead sponsor
Universiteit Antwerpen
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
February 19, 2023
Enrollment
17,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, onchocerciasis